Literature DB >> 1708809

The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera.

J M Moulds1, M W Nickells, J J Moulds, M C Brown, J P Atkinson.   

Abstract

Erythrocytes (E) lacking high incidence blood group antigens were screened by an antiglobulin test with a monoclonal antibody to human complement receptor type 1 (CR1; C3b/C4b receptor; CD35). Some examples of E lacking Knops, McCoy, Swain-Langley, and York antigens, a serologically related group, were not agglutinated. Moreover, E of the null phenotype for these same antigens were nonreactive. To further explore this relationship, E expressing these antigens were surface labeled, solubilized, and incubated with the corresponding blood group-specific antisera. CR1 was immunoprecipitated, indicating that the epitopes recognized by each of these antisera are expressed on CR1. E of two individuals, putative null phenotypes for the Knops, McCoy, and Swain-Langley blood group antigens, expressed a very low number of CR1 (less than 30/E; approximately 10% of the normal mean). This observation accounts for their lack of reactivity in the antiglobulin test and their prior designation as null phenotypes. Also, the previously reported low as well as variable expression of CR1 on E explains prior difficulties in the serologic analyses of these blood group antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708809      PMCID: PMC2118866          DOI: 10.1084/jem.173.5.1159

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

Review 1.  The regulators of complement activation (RCA) gene cluster.

Authors:  D Hourcade; V M Holers; J P Atkinson
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  Polymorphism of human erythrocyte C3b/C4b receptor.

Authors:  T R Dykman; J L Cole; K Iida; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

4.  Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.

Authors:  M K Moulds
Journal:  Am J Med Technol       Date:  1981-10

5.  Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele.

Authors:  T R Dykman; J A Hatch; M S Aqua; J P Atkinson
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

6.  The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.

Authors:  S Van Dyne; V M Holers; D M Lublin; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.

Authors:  V M Holers; T Seya; E Brown; J J O'Shea; J P Atkinson
Journal:  Complement       Date:  1986

8.  Ontogeny of B lymphocytes. 3. H-2 linkage of a gene controlling the rate of appearance of complement receptor lymphocytes.

Authors:  M C Gelfand; D H Sachs; R Lieberman; W E Paul
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

9.  Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.

Authors:  W W Wong; J M Cahill; M D Rosen; C A Kennedy; E T Bonaccio; M J Morris; J G Wilson; L B Klickstein; D T Fearon
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Human genes for three complement components that regulate the activation of C3 are tightly linked.

Authors:  S Rodriguez de Cordoba; D M Lublin; P Rubinstein; J P Atkinson
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  16 in total

1.  Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species.

Authors:  E V Ruggieri; P J Bugelski; J M Kaplan; D Everitt; J Lipani; D K Jorkasky; S C Boike; F DeClement; F D Moore; D J Herzyk
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

Review 2.  Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors:  Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

Review 3.  Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans.

Authors:  L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

4.  Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.

Authors:  Yuzhou Zhang; Carla M Nester; Danniele G Holanda; Henry C Marsh; Russell A Hammond; Lawrence J Thomas; Nicole C Meyer; Lawrence G Hunsicker; Sanjeev Sethi; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2013-08-01       Impact factor: 10.121

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  Protection of host cells by complement regulators.

Authors:  Christoph Q Schmidt; John D Lambris; Daniel Ricklin
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

7.  Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.

Authors:  S Sadallah; C Hess; M Trendelenburg; C Vedeler; M Lopez-Trascasa; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 8.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

9.  Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya.

Authors:  Vandana Thathy; JoAnn M Moulds; Bernard Guyah; Walter Otieno; José A Stoute
Journal:  Malar J       Date:  2005-11-08       Impact factor: 2.979

10.  Identification of the Kna/Knb polymorphism and a method for Knops genotyping.

Authors:  J M Moulds; B J Thomas; O Doumbo; D A Diallo; K E Lyke; C V Plowe; J A Rowe; D J Birmingham
Journal:  Transfusion       Date:  2004-02       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.